(IN BRIEF) SCHOTT Pharma has pre-validated its SCHOTT TOPPAC® ISO-standardized polymer cartridge for compatibility with SHL Medical’s Maggie® large-volume autoinjector platform. The collaboration delivers a ready-to-use, de-risked solution for administering highly sensitive biologics in large volumes, supporting self-injection and home-care … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, Pharma & Biotech, Science, Technology
Tagged Andreas Reisse, biologics administration, biosimilars, cell and gene therapy delivery, home care drug delivery, ISO standardized cartridge, large volume drug delivery, Maggie autoinjector, Markus Puusepp, pharmaceutical packaging, polymer cartridge, ready to use packaging, SCHOTT iQ platform, SCHOTT Pharma, SCHOTT Pharma Pre-Validates Polymer Cartridge with SHL Medical’s Maggie Autoinjector Platform, SCHOTT TOPPAC, SCHOTT TOPPAC Polymer Cartridge Achieves Compatibility with SHL Medical Large-Volume Autoinjectors, self injection devices, SHL Medical
(IN BRIEF) GEA is equipping the new Veterinary Vaccine Institute in Huambo, Angola, with advanced separation and aseptic valve technology, including a CSC 6 disc centrifuge, a CIP system and GEA VESTA® sterile valves. Scheduled for commissioning in autumn 2026, … Read the full press release
Posted in Agriculture, Business, Financial, Germany, Government, Industrial, Infrastructure & Utilities, Investment, Management, Pharma & Biotech, Science, Technology
Tagged agricultural development Angola, Angola vaccine production, animal vaccines Africa, aseptic processing technology, biopharmaceutical equipment, bioveterinary centre, cGMP compliant equipment, CIP SIP processing, Clean in Place system, CSC 6 disc centrifuge, GAUFF Engineering, GEA, GEA Hydrostop, GEA Supplies Advanced Separation Technology for New Veterinary Vaccine Institute in Angola, GEA Technology to Power New Veterinary Vaccine Centre in Huambo Angola, GEA VESTA sterile valves, hydrohermetic feed system, MINAGRIF, Ministry of Agriculture and Forestry Angola, NORÁFRICA, Veterinary Vaccine Institute Huambo
(IN BRIEF) The European Investment Bank, via EIB Global, has invested $37.5 million in Alta Semper Fund II to support pharmaceutical, life sciences and MedTech companies across Africa, with a primary focus on North Africa. The fund is expected to … Read the full press release
Posted in Banks, Business, European Union, Financial, Healthcare, Internet & Online, Investment, Luxembourg, News, Pharma & Biotech
Tagged Afsane Jetha, Alta Semper Capital, Alta Semper Fund II, Cheick Oumar Sylla, EIB Commits $37.5 Million to Alta Semper Fund II to Boost Healthcare Investment in Africa, EIB Global, EIB Investment in Alta Semper Fund II Aims to Catalyse $150 Million for African Healthcare Sector, EU Africa cooperation, EU Global Health Strategy, European Investment Bank, Gelsomina Vigliotti, gender equality investment, Global Gateway, Healthcare Innovation, healthcare investment Africa, life sciences investment, MedTech investment, North Africa healthcare, pharmaceutical sector Africa, private equity Africa, Rania Al Mashat, women led funds
(IN BRIEF) DNV has partnered with Korean diagnostics company Noul to certify its AI-powered malaria, blood cell and cervical cancer testing solutions under the EU In Vitro Diagnostic Medical Device Regulation. Acting as an IVDR Notified Body, DNV will assess … Read the full press release
Posted in Artificial Intelligence (AI), Business, Healthcare, Industrial, Management, News, Norway, Pharma & Biotech, Technology
Tagged AI diagnostics, blood cell morphology, CE marking, Cecilie Gudesen Torp, cervical cancer testing, diagnostic technology, DNV, DNV and Noul Collaborate to Advance EU Certification for AI-Powered Medical Diagnostics, DNV to Support IVDR Certification of Noul’s miLab Diagnostic Platform, EU Medical Device Regulation, Healthcare Innovation, in vitro diagnostic devices, IVDR certification, malaria diagnosis, medical device certification, miLab platform, Noul, point of care diagnostics, Taehwan Kim
(IN BRIEF) Basilea Pharmaceutica has partnered with INCATE, the European incubator for antibacterial therapies, to support the advancement of early-stage anti-infective innovations. As an industry partner, Basilea brings deep expertise in antibacterial and antifungal drug development, while expanding INCATE’s scope … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Investment, Management, Marketing, Non Profit, Pharma & Biotech, Science, Security & Safety, Switzerland, Technology
Tagged anti-infectives, antibacterial therapies, antifungal therapies, antimicrobial resistance, Basel life sciences, Basilea Joins INCATE to Advance Early-Stage Antibacterial and Antifungal Innovation in Europe, Basilea Pharmaceutica, biopharmaceutical innovation, clinical development, drug development, INCATE, industry partnership, infectious diseases, invasive fungal infections, Laurenz Kellenberger, preclinical research, Primo Schär, University of Basel
(IN BRIEF) Researchers at the Luxembourg Institute of Health have published a major review in Nature Cancer proposing a new framework to explain and potentially overcome the long-standing resistance of glioblastoma to immunotherapy. The study analyses how this aggressive brain … Read the full press release
Posted in Education, Healthcare, Industrial, Luxembourg, Management, Marketing, News, Pharma & Biotech, Science, Technology
Tagged brain cancer, cancer immunology, cancer research, Department of Cancer Research, glioblastoma, immune plasticity, immune resistance, immunotherapy, LIH, Luxembourg Institute of Health, Nature Cancer, Nature Cancer Review Reveals Why Immunotherapy Fails in Glioblastoma and How to Rethink Treatment, neuro-oncology, NORLUX Neuro-Oncology Laboratory, NORLUX Scientists Propose Immune Microenvironment Framework for Next-Generation Glioblastoma Therapies, oncology innovation, T cells, tumour microenvironment, tumour-associated macrophages
(IN BRIEF) EQT Life Sciences has exited its investment in Vivasure Medical following the sale of the Irish medical technology company to Haemonetics. Backed by EQT since 2016, Vivasure developed the PerQseal® Elite system, a bioabsorbable, sutureless solution for large-bore … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Ireland, Management, Pharma & Biotech, Science, Sweden, Technology
Tagged Anne Portwich, endovascular interventions, EQT Life Sciences, EQT Life Sciences Exits Vivasure Medical Following Sale to Haemonetics, Galway Ireland, Haemonetics, healthcare investment, life sciences, LSP Health Economics Fund, medical technology, PerQseal Elite, structural heart procedures, vessel closure systems, Vivasure Medical
(IN BRIEF) EQT Life Sciences has invested in U.S.-based Kinaset Therapeutics as part of a USD 103 million oversubscribed Series B financing. The funding will support the clinical advancement of frevecitinib, a novel inhaled pan-JAK inhibitor designed to treat a … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Sweden, Technology
Tagged asthma treatment, biopharmaceuticals, clinical-stage biotech, Daniela Begolo, EQT Life Sciences, EQT Life Sciences Backs Kinaset Therapeutics in USD 103m Series B Financing, Forge Life Science Partners, frevecitinib, inhaled therapeutics, Kinaset Therapeutics, pan-JAK inhibitor, RA Capital Management, respiratory diseases, Series B financing
(IN BRIEF) The European Commission has approved Sanofi’s Teizeild as the first disease-modifying therapy in the EU to delay the onset of stage 3 type 1 diabetes in adults and children with stage 2 T1D. Supported by TN-10 phase 2 … Read the full press release
Posted in Business, European Union, Financial, France, Government, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Security & Safety, Technology
Tagged autoimmune disease, beta cell function, CHMP, clinical approval, disease modifying therapy, EMA, European Commission, Sanofi, Sanofi’s Teizeild Becomes First EU-Approved Therapy to Delay Type 1 Diabetes Progression, T1D, Teizeild, teplizumab, TN-10 study, type 1 diabetes
(IN BRIEF) ShanX Medtech, a spin-off from Eindhoven University of Technology, has raised €24 million in combined public and private funding to accelerate the development of its ultra-rapid antimicrobial susceptibility testing platform. The financing includes an oversubscribed €15 million seed … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Netherlands, News, Pharma & Biotech, Science, Technology
Tagged AMR, antimicrobial resistance, antimicrobial susceptibility testing, Ardjan van der Linden, AST, Borski Fund, Brabant Development Agency, Eindhoven University of Technology, European Commission funding, HADEA, Hera, High Tech Campus Eindhoven, In Vitro Diagnostics, Invest-NL, Jaap den Toonder, MedTech innovation, New €24 Million Investment Positions ShanX Medtech for Clinical Launch of Rapid AST Technology, ShanX Medtech, Sophia E Shanko, TU/e spin-off
(IN BRIEF) Basilea Pharmaceutica has entered into a strategic collaboration with Prokaryotics to develop a first-in-class broad-spectrum antifungal therapy targeting severe invasive fungal infections. The partnership focuses on novel compounds with a new mode of action aimed at pathogens such … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Switzerland, Technology
Tagged anti-infective research, antifungal drug development, Aspergillus, Basilea Partners with Prokaryotics to Develop Novel Broad-Spectrum Antifungal Therapy, Basilea Pharmaceutica, biopharmaceutical collaboration, Candida, clinical development, first in class antifungal, global licensing agreement, invasive fungal infections, Laurenz Kellenberger, novel mode of action, Prokaryotics, rare molds, Terry Roemer
(IN BRIEF) GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s Ministry of Health, Labour and Welfare, the therapy delivers sustained disease control … Read the full press release
Posted in Business, Financial, Government, Healthcare, Industrial, Investment, Management, Pharma & Biotech, Science, Technology, United Kingdom
Tagged ANCHOR trials, asthma exacerbations, chronic rhinosinusitis with nasal polyps, CRSwNP, Depemokimab, Exdensur, Exdensur Gains Approval in Japan, Expanding GSK’s Respiratory Biologic Portfolio, GSK, GSK’s Depemokimab Approved in Japan, interleukin 5, Introducing New Option for Severe Asthma Care, Japan Ministry of Health Labour and Welfare, Kaivan Khavandi, Nasal Polyps, respiratory medicine, Severe Asthma, SWIFT trials, type 2 inflammation, ultra long acting biologic
(IN BRIEF) GSK has received approval from China’s National Medical Products Administration for Nucala as an add-on maintenance therapy for adults with inadequately controlled COPD and elevated blood eosinophils. Supported by positive MATINEE and METREX phase III trial data, the … Read the full press release
Posted in Business, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged biologic therapy, blood eosinophil count, China Approves GSK’s Nucala to Reduce Exacerbations in Adults with COPD, China NMPA approval, Chronic obstructive pulmonary disease, COPD treatment, eosinophilic COPD, exacerbation reduction, GSK, IL-5 monoclonal antibody, Kaivan Khavandi, MATINEE trial, mepolizumab, METREX trial, Nucala, respiratory medicine
(IN BRIEF) Fraunhofer researchers have developed a targeted oral care technology that selectively inhibits periodontitis-causing bacteria while preserving the beneficial oral microbiome. The innovation, created at Fraunhofer IZI and commercialized by the spin-off PerioTrap, avoids the drawbacks of conventional antiseptic … Read the full press release
Posted in Business, Germany, Healthcare, Pharma & Biotech, Science, Technology
Tagged biotechnology spin off, dental health innovation, Fraunhofer, Fraunhofer IZI, Fraunhofer Researchers Enable Targeted Oral Care to Prevent Periodontitis, GLP standards, gum disease research, microbiome friendly oral care, oral microbiome, periodontitis prevention, PerioTrap, Porphyromonas gingivalis, professional dental care, selective inhibition, toothpaste development
(IN BRIEF) Sanofi’s Tzield has been accepted for priority review by the U.S. Food and Drug Administration to expand its use to children aged one year and older with stage 2 type 1 diabetes. The submission is supported by interim … Read the full press release
Posted in France, Healthcare, Pharma & Biotech
Tagged autoimmune disease, beta cell protection, Christopher Corsico, clinical development, disease modifying therapy, FDA priority review, pediatric diabetes, pediatric endocrinology, PETITE T1D study, regulatory review, Sanofi, Sanofi’s Tzield Receives FDA Priority Review for Use in Young Children with Stage 2 Type 1 Diabetes, stage 2 T1D, teplizumab mzwv, type 1 diabetes, TZIELD
(IN BRIEF) Evotec SE has created a new Executive Vice President role that combines Global Communications and Investor Relations as part of a broader effort to strengthen strategic clarity and stakeholder engagement. Dr. Sarah Fakih has been appointed to lead … Read the full press release
Posted in Business, Germany, Healthcare, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged capital markets strategy, Christian Wojczewski, Corporate Communications, CureVac, Evotec SE, executive appointment, Global Communications, Hamburg Germany, Investor Relations, life sciences leadership, MorphoSys, QIAGEN, Sarah Fakih, stakeholder engagement, Volker Braun
(IN BRIEF) The Institute of Cancer Research has led a study showing that chromosomal instability in circulating tumour cells can predict resistance to cabazitaxel in men with advanced prostate cancer. Using blood samples from more than 200 patients enrolled in … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Blood test developed by ICR researchers may guide treatment decisions in advanced prostate cancer, cabazitaxel, CARD trial, chemotherapy resistance, chromosomal instability, circulating tumour cells, JCI Insight, liquid biopsy, mCRPC, metastatic castration-resistant prostate cancer, oncology biomarkers, personalised cancer treatment, Prostate Cancer Research, Sanofi, The Institute of Cancer Research London
(IN BRIEF) ZEISS has launched its labs@location program in Australia, naming the Walter and Eliza Hall Institute of Medical Research’s Centre for Dynamic Imaging as its first local partner. The collaboration brings ZEISS’ advanced microscopy technologies together with WEHI’s long-standing … Read the full press release
Posted in Business, Electronics & Machinery, Germany, Healthcare, Investment, News, Pharma & Biotech, Science, Technology
Tagged advanced imaging, Australia research collaboration, biomedical research, cancer research, Centre for Dynamic Imaging, Disease Research, Dr René Hessling, imaging workflows, infection and immunity, labs@location, lifelong health, microscopy innovation, Professor Kelly Rogers OAM, research infrastructure, scientific collaboration, Walter and Eliza Hall Institute of Medical Research, WEHI, ZEISS, ZEISS Australia and New Zealand, ZEISS Expands Global labs@location Network to Australia Through WEHI Collaboration
(IN BRIEF) The EBRD is providing a €14 million loan to Farmalogist to build a new, energy-efficient logistics centre in Belgrade, with €1.2 million in concessional financing from the Global Environment Fund. The project will centralise and automate operations, significantly … Read the full press release
Posted in Banks, Financial, Industrial, Infrastructure & Utilities, Investment, Pharma & Biotech, Serbia, Technology, Transportation & Logistics, United Kingdom
Tagged automation, Belgrade, CERI, circular economy, Circular Economy Regional Initiative, EBRD, EBRD Backs Circular Economy-Driven Logistics Investment for Farmalogist in the Western Balkans, energy efficiency, European Bank for Reconstruction and Development, Farmalogist, GEF, Global Environment Fund, Green Economy Transition, Janko Radunovic, logistics centre, Matteo Colangeli, pharmaceutical distribution, renewable energy, SERBIA, supply chain modernisation, sustainable logistics
(IN BRIEF) A nationwide retrospective study presented at EACVI 2025 found that AI-derived fractional flow reserve from coronary CT (FFR-CT) is a strong independent predictor of future cardiovascular events in patients undergoing evaluation for suspected stable coronary artery disease. Using … Read the full press release
Posted in Artificial Intelligence (AI), Austria, Business, Education, France, Healthcare, Industrial, Management, Marketing, News, Non Profit, Pharma & Biotech, Science, Technology
Tagged AI-Derived Coronary Flow Assessment Identifies High-Risk Patients in Stable Coronary Artery Disease, artificial intelligence imaging, CAD, cardio-oncology, cardiovascular mortality, CCTA, clinical outcomes, Coronary Artery Disease, coronary computed tomography angiography, CT-derived fractional flow reserve, EACVI 2025, ESC, FFR-CT, FISH&CHIPS study, Jack Bell, myocardial infarction risk, Non-invasive Imaging, prognostic imaging, revascularisation, Timothy Fairbairn, Vienna
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?